Skip to main content
. 2006 May 9;114(9):1471–1478. doi: 10.1289/ehp.8949

Table 4.

Select epidemiologic studies: site-specific cancer and exposure to TCE.

Reference Study population Exposed cases (no.) Estimated relative risk (95% CI)
Total cancer
 Cohort studies
  Hansen et al. 2001 Male 109 1.0 (0.9–1.3)
Female 19 1.0 (0.6–1.6)
  Chang et al. 2003 Male 66 0.7 (0.5–0.8)
Female 250 1.0 (0.9–1.1)
  Raaschou-Nielsen et al. 2003 Male 2,434 1.1 (1.0–1.1)
Female 624 1.2 (1.1–1.3)
 Community studies
  Lee et al. 2003 Upstream village 266a 1.0
Downstream village 2.1 (1.3–3.3)b
  Morgan and Cassady 2002 13 census tracts in San Bernardino County, CA 3,098 1.0 (0.9–1.0)
Bladder
 Cohort studies
  Hansen et al. 2001 Male 10 1.1 (0.5–2.0)
Female 0
  Chang et al. 2003 Male 1 1.0 (0.01–5.4)
Female 1 1.0 (0.01–5.4)
  Raaschou-Nielsen et al. 2003 Male 203 1.0 (0.9–1.2)
Female 17 1.6 (0.9–2.6)
  Zhao et al. 2005c Low TCE score 7 1.0
Medium TCE score 7 1.5 (0.8–2.9)
High TCE score 3 2.0 (0.9–4.2)
 Case–control studies
  Pesch et al. 2000b JTEM, male
Medium TCE exposure 47 0.8 (0.6–1.2)
High TCE exposure 74 1.3 (0.9–1.7)
Substantial TCE exposure 36 1.8 (1.2–2.7)
 Community studies
  Morgan and Cassady 2002 13 census tracts in San Bernardino County, CA 82 1.0 (0.8–1.2)
Breast
 Cohort studies
  Hansen et al. 2001 Female 4 0.9 (0.2–2.3)
  Chang et al. 2005 Female 215 1.2 (1.0–1.4)
  Raaschou-Nielsen et al. 2003 Male 2 0.5 (0.1–1.9)
Female 145 1.1 (0.9–1.2)
 Community studies
  Morgan and Cassady 2002 Females in 13 census tracts in San Bernardino County, CA 536 1.1 (1.0–1.2)
Esophagus
 Cohort studies
  Hansen et al. 2001 Male 6 4.2 (1.5–9.2)
Female 0
  Chang et al. 2005 Male 0
Female 0
  Raaschou-Nielsen et al. 2003 Male 23d 1.8 (1.2–2.7)
Female 0
  Zhao et al. 2005c,e Low TCE score 7 1.0
Medium TCE score 7 1.7 (0.6–4.4)
High TCE score 3 1.3 (0.2–4.0)

CI, confidence interval.

a

Total cancer deaths in the two villages.

b

99% CI.

c

Zhao et al. (2005) present both cancer incidence and cancer mortality. Relative risks in this table are for cancer incidence.

d

Adenocarcinoma of the esophagus.

e

Esophageal and stomach cancer incidence.